Doctor profile · Federal record
Dr. Kai Zu, M.D.
Hematology & Oncology Physician (CMS: Hematology/Oncology) · La Mesa, CA
- NPI 1164583639
- Accepts Medicare
- MIPS 100.0 / 100 · 2023
- 36 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
5555 Grossmont Center Dr
La Mesa, CA 919423019
(619) 644-3030
fax (619) 644-3438
Credentials & registration
- NPI registered
- December 2006 — 20 yrs on file
- Profile last updated
- August 13, 2010
- Year of graduation
- 1990 — 36 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- California #A74842
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1164583639. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
193,945
Distinct HCPCS
10
Medicare allowed
$2,133,293
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 73,675 | 35 | $3 | |
J1439 |
Injection, ferric carboxymaltose, 1 mg | 59,250 | 36 | $1 | |
J9299 |
Injection, nivolumab, 1 mg | 50,040 | 14 | $30 | |
J0897 |
Injection, denosumab, 1 mg | 4,020 | 16 | $23 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 2,015 | 30 | $0 | |
J2469 |
Injection, palonosetron hcl, 25 mcg | 1,540 | 26 | $1 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 803 | 379 | $96 | |
96372 |
Injection of drug or substance under skin or into muscle | 485 | 67 | $15 | |
96375 |
Injection of additional new drug or substance into vein | 405 | 36 | $17 | |
96413 |
Administration of chemotherapy into vein, 1 hour or less | 375 | 53 | $150 |
In context: peer comparison
Among 3 peers in this city , average services per provider: 5,156. This provider delivers 38× the peer median.Open Payments
Industry payments received
All-time total
$3,291
Transactions
43
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $2,225.31 | |
| PFIZER INC. | 9 | $183.95 | |
| E.R. Squibb & Sons, L.L.C. | 6 | $128.99 | |
| Novartis Pharmaceuticals Corporation | 4 | $88.80 | |
| Celgene Corporation | 3 | $72.77 | |
| Eisai Inc. | 3 | $68.40 | |
| ABBVIE INC. | 3 | $65.31 | |
| Alexion Pharmaceuticals, Inc. | 2 | $60.82 | |
| Gilead Sciences, Inc. | 2 | $55.05 | |
| Astellas Pharma US Inc | 2 | $53.62 | |
| Novo Nordisk Inc | 2 | $46.93 | |
| PharmaEssentia USA Corporation | 1 | $33.29 | |
| BeiGene USA, Inc. | 1 | $28.89 | |
| Regeneron Healthcare Solutions, Inc. | 1 | $26.76 | |
| SpringWorks Therapeutics, Inc. | 1 | $25.24 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
773
Patients
140
Total drug cost
$1,764,921
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Anastrozole | Generic | 172 | 35 | $4,243 |
| Ondansetron Hcl | Generic | 81 | 32 | $1,117 |
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 69 | 16 | $1,999 |
| Morphine Sulfate Er (Morphine Sulfate) | Brand | 59 | 11 | $2,155 |
| Levothyroxine Sodium | Generic | 58 | 0 | $735 |
| Reblozyl (Luspatercept-Aamt) | Brand | 58 | 0 | $749,553 |
| Potassium Chloride | Generic | 46 | 16 | $617 |
| Hydroxyurea | Generic | 38 | 0 | $1,437 |
| Omeprazole | Generic | 37 | 13 | $428 |
| Aranesp (Darbepoetin Alfa In Polysorbat) | Brand | 28 | 0 | $115,646 |
Hospital affiliations
Frequently asked questions
What is Dr. Kai Zu's medical specialty?
Dr. Kai Zu practices Hematology & Oncology Physician in La Mesa, CA.
Where does Dr. Kai Zu practice?
Dr. Kai Zu practices at 5555 Grossmont Center Dr, La Mesa, CA 919423019. Office phone: 6196443030.
What is Dr. Kai Zu's NPI?
Dr. Kai Zu's National Provider Identifier (NPI) is 1164583639, issued by NPPES.
Does Dr. Kai Zu accept Medicare assignment?
Yes. Dr. Kai Zu accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Kai Zu commonly perform?
Top Medicare-reported procedures in 2023: Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS J0881); Injection, ferric carboxymaltose, 1 mg (HCPCS J1439); Injection, nivolumab, 1 mg (HCPCS J9299). Source: CMS Medicare Physician & Other Practitioners file.